Viewing Study NCT02449603


Ignite Creation Date: 2025-12-24 @ 7:40 PM
Ignite Modification Date: 2026-02-25 @ 9:50 PM
Study NCT ID: NCT02449603
Status: COMPLETED
Last Update Posted: 2018-11-14
First Post: 2015-05-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparison of Exenatide vs. Biphasic Insulin Aspart 30 on Glucose Variability in Type 2 Diabetes
Sponsor: Xijing Hospital
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: ESR-14-10319
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None UNKNOWN View